Context Therapeutics (CNTX) Amortizatization of Intangibles (2022 - 2026)
Context Therapeutics' (CNTX) quarterly Amortizatization of Intangibles came in at $31418.0 in Q1 2026, up 20.78% year-on-year from $26012.0 in Q1 2025, and up 14.43% quarter-over-quarter from $27457.0 in Q3 2025.
Context Therapeutics (CNTX) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Context Therapeutics has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $31418.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Context Therapeutics | 166.57 Mn | 166.57 Mn | - | 31,418.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,418.00 |
| Mar 31, 2026 | 31,418.00 |
| Sep 30, 2025 | 27,457.00 |
| Sep 30, 2025 | 27,457.00 |
| Jun 30, 2025 | 26,725.00 |
| Jun 30, 2025 | 26,725.00 |
| Mar 31, 2025 | 26,012.00 |
| Mar 31, 2025 | 26,012.00 |
| Sep 30, 2024 | 14.75 Mn |
| Sep 30, 2024 | 14.75 Mn |
| Sep 30, 2023 | 7,522.00 |
| Sep 30, 2023 | 7,522.00 |
| Jun 30, 2023 | 22,370.00 |
| Jun 30, 2023 | 22,370.00 |
| Mar 31, 2023 | 22,075.00 |
| Mar 31, 2023 | 22,075.00 |
| Sep 30, 2022 | 21,499.00 |
| Sep 30, 2022 | 21,499.00 |
| Jun 30, 2022 | 21,216.00 |
| Jun 30, 2022 | 21,216.00 |